BFR Therapy for ACL Reconstruction Rehab
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if adding blood flow restriction (BFR) therapy to standard rehabilitation improves recovery after anterior cruciate ligament (ACL) surgery. Participants are divided into two groups: one receives standard rehabilitation, while the other receives standard rehabilitation plus BFR therapy. The trial targets active duty or Department of Defense beneficiaries who require ACL reconstruction using their own quadriceps tendon and have no growth plate issues. As an unphased trial, it provides a unique opportunity to explore innovative recovery methods.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that BFR therapy is safe for ACL reconstruction rehab?
Research has shown that blood flow restriction (BFR) therapy is generally safe for individuals recovering from ACL (anterior cruciate ligament) surgery. Studies have found that patients not only find BFR therapy safe but also well-received. Many patients express satisfaction with this therapy when combined with light exercises.
Although BFR therapy might not immediately enhance muscle strength, it can help maintain muscle and bone health after ACL surgery. No major safety issues have been reported, making it a promising option for those seeking to improve their recovery after ACL reconstruction.12345Why are researchers excited about this trial?
Unlike the standard of care for ACL reconstruction rehabilitation, which involves traditional physical therapy exercises, BFR (Blood Flow Restriction) therapy is gaining attention for its unique approach. BFR therapy works by partially restricting blood flow to the muscles during low-intensity exercise, which can enhance muscle strength and recovery more efficiently. Researchers are excited because this method may accelerate rehabilitation, allowing patients to regain function faster than with standard rehab alone. Plus, it could reduce the overall stress on healing tissues, potentially leading to safer recovery outcomes.
What evidence suggests that BFR therapy is effective for ACL reconstruction rehab?
Research has shown that Blood Flow Restriction (BFR) therapy might aid recovery after ACL surgery. In this trial, participants will receive either the standard post-operative rehabilitation regimen (REHAB) or the standard regimen with BFR therapy (REHAB + BFR). Some studies have found that BFR can increase thigh muscle strength, which is crucial for rehabilitation. However, other research suggests that BFR is not always superior to regular therapy. Some patients using BFR have reported less pain and improved knee function. Overall, while BFR therapy appears promising, results can vary among individuals.12367
Who Is on the Research Team?
Andrew J Sheean, MD
Principal Investigator
Brooke Army Medical Center
Are You a Good Fit for This Trial?
This trial is for active duty members or beneficiaries of the Department of Defense Military Health System, aged 15-45, who need ACL reconstruction with quadriceps tendon autograft and have mature skeletons. Excluded are those needing other surgeries affecting mobility, unable to follow rehab consistently, can't get MRIs due to intolerance/device interference, having multiple knee ligament reconstructions or recent leg vein clots.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Assessment
MRI of bilateral thighs and isokinetic and isometric strength measurements are performed to establish baseline
Treatment
Participants undergo ACL reconstruction surgery followed by a 12-week post-operative rehabilitation regimen with or without BFR therapy
Mid-term Follow-up
Patient reported outcomes and MRI assessments at 24 and 36 weeks post-operative to monitor progress
Long-term Follow-up
Final assessments including MRI and patient reported outcomes at 52 weeks post-operative to evaluate long-term effects
What Are the Treatments Tested in This Trial?
Interventions
- Blood Flow Restriction (BFR) therapy
- Standard REHAB
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brooke Army Medical Center
Lead Sponsor
Congressionally Directed Medical Research Programs
Collaborator
American Orthopaedic Society for Sports Medicine
Collaborator